Appointment booking for Dr. Matthew Matasar, MD is currently not available.Dr. Matthew Matasar, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Matthew Matasar, MD (he/him) is a Oncologist in New York, NY with over 16 years of experience. What is your opinion of Dr. Matthew Matasar, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 16 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Matthew Matasar, MD has received over $130,928 which includes payments from the following companies:
$41,949.79 from Genentech, Inc.
$31,677.27 from Bayer HealthCare Pharmaceuticals Inc.
$20,896.53 from F. Hoffmann-La Roche AG
$20,356.23 from Genentech USA, Inc.
$5,820.00 from Daiichi Sankyo Inc.
$3,325.00 from GENZYME CORPORATION
$2,666.70 from Janssen Scientific Affairs, LLC
$1,937.50 from Karyopharm Therapeutics Inc.
$1,199.75 from Seattle Genetics, Inc.
$450.00 from BeiGene, Ltd.
$400.00 from Spectrum Pharmaceuticals Inc.
$250.00 from COMSORT, Inc
Payments received by Dr. Matthew Matasar, MD were from the following categories:
$100,332.58 Consulting Fee
$14,634.58 Travel and Lodging
$11,373.79 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!